Category: Financial

LIN Report

The Longevity Investor Network Looks Back at 2025

The Longevity Investor Network (LIN) was created to help bridge the gap between promising longevity startups and the investors capable of helping them scale. Through curated monthly pitch sessions, educational

Immortal Dragons logo

Immortal Dragons Launches $40M Longevity Fund

Immortal Dragons, a purpose-driven longevity fund headquartered in Singapore, today announced its unique approach to investing in radical life extension technologies. With $40 million in assets under management (AUM), Immortal

Long Game

LongGame Venture Capital Fund Officially Launched

Crypto investor and founder Will Harborne will lead a new enterprise aimed at funding and supporting groundbreaking longevity technologies. From crypto to longevity The burgeoning field of longevity biotech is

Longevity Desci Recap July 2024

Longevity and DeSci Recap – July 2024

The Longevity and DeSci Recap is back, and our latest edition covers high-profile events including the Longevity Investors Conference in Gstaad, new innovations in AFib monitoring, and even some celebrity-related

Longevity Desci Recap June 2024

Longevity and DeSci Recap – June 2024

This summer season is red hot in the world of longevity. Packed with interesting events, investments and new research proposals, the future of longevity is becoming today’s reality. Join us

Longevity Desci Recap May 2024

Longevity and DeSci Recap – May 2024

In this latest edition of the Longevity and DeSci Recap, we’ll take a look back at May’s events, research, and investments to give you the latest update on what’s going

Longevity Desci Recap April 2024

Longevity and DeSci Recap – April 2024

In this latest edition of the Longevity and DeSci Recap, we’ll be taking a look back over a month full of events, research, and investments. As we head into spring,

Desci March

Longevity and DeSci Recap – March 2024

Welcome back for the latest edition of the Longevity and DeSci Recap. This March has seen a swarm of activity as the longevity and DeSci world has sprung to renewed

Biotech investment

Lowering the Bar to Invest in Longevity

Maximon, Marcuard Heritage, and GenTwo have announced the launch of a new longevity-related investment opportunity. Their proposal allows professional investors to get access to Maximon’s portfolio of longevity companies via

Longevity DeSci Feb 2024

Longevity and DeSci Recap – February 2024

Last month has been a hive of activity in the longevity finance sphere, with a number of significant fundings taking place that are set to generate new lifespan solutions for

Desci January

Longevity and DeSci Recap – January 2024

Welcome back to the latest edition of the Longevity and DeSci Recap and the first of 2024. The past year has been packed with new discoveries and releases, including Exo’s

LIN Report

Longevity Investor Network 2023 End of Year Update

The Longevity Investor Network has experienced significant growth and success over the past year. Our mission to connect innovative companies in the longevity sector with forward-thinking investors has seen remarkable

Desci November

Longevity and DeSci Recap – November 2023

Thanks for joining us again for the latest edition of the Longevity and DeSci Recap. This month’s highlights include fantastic conferences, such as the Rejuvenation Startup Summit 2024 in Berlin,

Todd White Interview

The Thalion Initiative: A New Non-Profit With Big Ambitions

The longevity field remains small and starved for resources, especially the subfield devoted to the fundamental biology of aging, despite near-universal agreement that solving aging requires understanding it first. With VCs looking for clinical successes and state funding drying up for many projects, some enthusiasts are

LIN Report

The Longevity Investor Network Looks Back at 2025

The Longevity Investor Network (LIN) was created to help bridge the gap between promising longevity startups and the investors capable of helping them scale. Through curated monthly pitch sessions, educational seminars, collaborative diligence, and ecosystem-building events, LIN provides a structured platform for investors to discover, evaluate,

Insilico Medicine

Insilico and Eli Lilly Announce a Major Collaboration

Building on two previous deals between the companies, this new agreement is potentially worth up to $2.75 billion and involves Lilly licensing assets from Insilico’s pipeline. More than software Earlier this week, the AI-driven drug discovery company Insilico Medicine announced a large-scale collaboration with the pharmaceutical

Immortal Dragons logo

Immortal Dragons Launches $40M Longevity Fund

Immortal Dragons, a purpose-driven longevity fund headquartered in Singapore, today announced its unique approach to investing in radical life extension technologies. With $40 million in assets under management (AUM), Immortal Dragons is poised to redefine how capital fuels scientific breakthroughs in longevity and healthspan. At its

Long Game

LongGame Venture Capital Fund Officially Launched

Crypto investor and founder Will Harborne will lead a new enterprise aimed at funding and supporting groundbreaking longevity technologies. From crypto to longevity The burgeoning field of longevity biotech is about to have a new player. Like many recent enterprises, such as Brian Armstrong’s NewLimit, this

Longevity Desci Recap July 2024

Longevity and DeSci Recap – July 2024

The Longevity and DeSci Recap is back, and our latest edition covers high-profile events including the Longevity Investors Conference in Gstaad, new innovations in AFib monitoring, and even some celebrity-related news. This month, we’ll continue to explore the latest events, current research, and investment news to

Longevity Desci Recap June 2024

Longevity and DeSci Recap – June 2024

This summer season is red hot in the world of longevity. Packed with interesting events, investments and new research proposals, the future of longevity is becoming today’s reality. Join us as we run through the happenings of June 2024 and what’s been going on in the

Longevity Desci Recap May 2024

Longevity and DeSci Recap – May 2024

In this latest edition of the Longevity and DeSci Recap, we’ll take a look back at May’s events, research, and investments to give you the latest update on what’s going on in the Longevity and DeSci world. As the weather is heating up, so too are

Longevity Desci Recap April 2024

Longevity and DeSci Recap – April 2024

In this latest edition of the Longevity and DeSci Recap, we’ll be taking a look back over a month full of events, research, and investments. As we head into spring, renewed life is on the horizon with continued investments in the longevity sector and the announcement

Desci March

Longevity and DeSci Recap – March 2024

Welcome back for the latest edition of the Longevity and DeSci Recap. This March has seen a swarm of activity as the longevity and DeSci world has sprung to renewed life. Between the many upcoming conferences, latest investment news, and innovations happening at the Vitalia pop-up

Biotech investment

Lowering the Bar to Invest in Longevity

Maximon, Marcuard Heritage, and GenTwo have announced the launch of a new longevity-related investment opportunity. Their proposal allows professional investors to get access to Maximon’s portfolio of longevity companies via an actively managed certificate (AMC). According to Maximon, there have been many requests to launch an

Longevity DeSci Feb 2024

Longevity and DeSci Recap – February 2024

Last month has been a hive of activity in the longevity finance sphere, with a number of significant fundings taking place that are set to generate new lifespan solutions for the future. Highlights include Yuva Biosciences’ $7.5 million for anti-hair loss tech, Tagomics’ £6.7 million for

Desci January

Longevity and DeSci Recap – January 2024

Welcome back to the latest edition of the Longevity and DeSci Recap and the first of 2024. The past year has been packed with new discoveries and releases, including Exo’s Iris, a hand-held AI ultrasound device; large-scale deals, such as Fauna Bio x Lilly at $494

LIN Report

Longevity Investor Network 2023 End of Year Update

The Longevity Investor Network has experienced significant growth and success over the past year. Our mission to connect innovative companies in the longevity sector with forward-thinking investors has seen remarkable achievements, particularly in 2023. Investors On the investor side, we have now over 200 longevity investors

Desci November

Longevity and DeSci Recap – November 2023

Thanks for joining us again for the latest edition of the Longevity and DeSci Recap. This month’s highlights include fantastic conferences, such as the Rejuvenation Startup Summit 2024 in Berlin, the Vitalia event in Roatan, and the large-scale Longevity Med Summit in Lisbon, along with many